STATUTORY RULES
1972 No.
REGULATIONS UNDER THE NATIONAL HEALTH ACT 1953-1971.*
WHEREAS it is provided by sub-section (4.) of section 101 of the National Health Act 1953-1971 that a drug or medicinal preparation that was not a pharmaceutical benefit under the National Health Act 1953-1958 immediately before the commencement of that sub-section shall not be prescribed as a pharmaceutical benefit in accordance with section 85 of that Act unless the Pharmaceutical Benefits Advisory Committee has recommended to the Minister that it be so prescribed:
AND WHEREAS that Committee has recommended to the Minister that the following drugs and medicinal preparations be prescribed as pharmaceutical benefits under section 85 of the National Health Act 1953-1971, namely, the drugs and medicinal preparations specified in the Third Schedule to the National Health (Pharmaceutical Benefits) Regulations, as amended by the following Regulations, that had not previously been prescribed as pharmaceutical benefits:
NOW THEREFORE I, THE ADMINISTRATOR of the Government of the Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Regulations under the National Health Act 1953-1971.
Dated this twenty-seventh day of July, 1972.
Rohan Delacombe
Administrator.
By His Excellency’s Command,
Amendments of the National Health (Pharmaceutical Benefits) Regulations†
Commencement.
1. These Regulations shall come into operation on the first day of August, 1972.
First Schedule.
2. The First Schedule to the National Health (Pharmaceutical Benefits) Regulations is amended as set out in the First Schedule to these Regulations.
Second Schedule.
3. The Second Schedule to the National Health (Pharmaceutical Benefits) Regulations is amended as set out in the Second Schedule to these Regulations.
Third Schedule.
4. The Third Schedule to the National Health (Pharmaceutical Benefits) Regulations is amended as set out in the Third Schedule to these Regulations.
Fifth Schedule.
5. The Fifth Schedule to the National Health (Pharmaceutical Benefits) Regulations is amended as set out in the Fourth Schedule to these Regulations.
* Notified in the Commonwealth Gazette on 1972.
† Statutory Rules 1960, No. 17, as amended by Statutory Rules 1960, Nos. 90 and 102; 1961, Nos. 59 and 137; 1962, Nos. 34, 101 and 114; 1963, Nos. 34, 69 and 107; 1964, Nos. 12, 57 and 135; 1965, Nos. 51, 151 and 152; 1966, Nos. 80 and 144; 1967, Nos. 67, 116 and 158; 1968, Nos. 44, 76, 88 and 146; 1969, Nos. 44, 107 and 185; 1970, Nos. 39, 94, 119 and 186; 1971, Nos. 44, 101, 136 and 154; and 1972, No. 32.
16263/72—Recommended retail price 8c 9/6.7.1912
THE SCHEDULES
FIRST SCHEDULE Regulation 2.
Amendments of the First Schedule to the National Health (Pharmaceutical
Benefits) Regulations
1. After item 59 insert the following item:—
“ 59a. Castor Oil ”.
2. After item 63 insert the following item:—
“ 63a. Chlorcyclizine Hydrochloride ”.
3. After item 136 insert the following item:—
“ 136a. Dichlorophen Tablets ”.
4. After item 174 insert the following item:—
“ 174a. Ethionamide Tablets ”.
5. After item 371 insert the following item:—
“ 371a. Phenylephrine Injection ”.
6. After item 384 insert the following item:—
“ 384a. Prednisolone Pivalate ”.
7. After item 394 insert the following item:—
“ 394a. Progesterone Injection ”.
8. After item 414 insert the following item:—
“ 414a. Senna Fruit ”.
9. After item 475 insert the following item:—
“ 475a. Thiambutosine ”.
SECOND SCHEDULE Regulation 3.
Amendments of the Second Schedule to the National Health (Pharmaceutical Benefits) Regulations
1. After item 40 insert the following item:—
“ 40a | Clemastine Hydrogen Fumarate | — ”. |
2. After item 85 insert the following item:—
“ 85a | Glucose and Ketone Indicator | — ”. |
3. Omit from item 94 “ Morphine Sulphate with Hyoscine Hydrobromide ” (in the third column).
4. Omit item 111.
5. Omit from item 122 “ Prednisolone Sodium Phosphate with Neomycin Sulphate ” (in the third, column).
6. After item 150 insert the following item:—
“ 150a | Phenethicillin, Benzathine.... | — ”. |
7. Omit item 167, insert the following item:—
“ 167 | Prednisolone Sodium Phosphate | — ”. |
8. Omit item 168.
9. Omit item 177.
THIRD SCHEDULE Regulation 4
Amendments of the Third Schedule to the National Health (Pharmaceutical Benefits) Regulations
1. Omit item 13.
2. After item 26 insert the following item:—
“ 26a. Amiloride Hydrochloride ”.
3. Omit item 46.
4. After item 80 insert the following item:—
“ 80a. Clemastine Hydrogen Fumarate ”.
5. After item 152 insert the following item:—
“ 152a. Glucose and Ketone Indicator ”.
6. Omit item 214.
7. Omit item 246.
8. After item 275 insert the following item:—
“ 275a. Phenethicillin, Benzathine ”.
FOURTH SCHEDULE
Regulation 5.
Amendments of the Fifth Schedule to the National Health (Pharmaceutical Benefits) Regulations
1. Omit item 5.
2. Omit item 13, insert the following item:— | ||
“ 13 | (1) Ampicillin Capsules, B.P. (2) Ampicillin Injections, Tablets and Syrups | Infections by organisms sensitive to Ampicillin where the infection cannot be safely and effectively treated with sulphonamides or with any of the following administered orally— |
|
| Benzylpenicillin |
|
| Phenoxymelhylpenicillin |
|
| Phenethicillin |
|
| Urinary tract infections by organisms where sulphonamide treatment has proved ineffective and positive bacteriological evidence confirms that the organisms are sensitive to Ampicillin |
|
| Urinary tract infections where the patient is sensitive to sulphonamides ”. |
3. Omit item 58.
4. Omit item 66, insert the following item:— | ||
“ 66 | Epicillin Capsules and Syrups | Infections by organisms sensitive to Epicillin where the infection cannot be safely and effectively treated with sulphonamides or with any of the following administered orally— |
|
| Benzylpenicillin |
|
| Phenoxymethylpenicillin |
|
| Phenethicillin |
|
| Urinary tract infections by organisms where sulphonamide treatment has proved ineffective and positive bacteriological evidence confirms that the organisms are sensitive to Epicillin |
|
| Urinary tract infections where the patient is sensitive to sulphonamides ”. |
5. Omit from item 94 “ Progesterone deficiency proved by hormonal assay, by lateral wall smear or by endometrial biopsy ” (in the third column).
FOURTH SCHEDULE—continued
6. Omit item 115, insert:— | ||||
“ 115 | Medroxyprogesterone Acetate | Carcinoma of the endometrium | ||
| Tablets, 2.5 mg. | Precocious puberty ”. | ||
7. Omit item 118, insert:— | ||||
“ 118 | Medroxyprogesterone Acetate Injections, 50 mg. in 1 ml. or 250 mg. in 5 ml. | Carcinoma of the endometrium | ||
|
| Hypernephroma ”. | ||
“ 118a | Medroxyprogesterone Acetate Injections, 150 mg. in 1 ml. | Carcinoma of the endometrium | ||
|
| Hypernephroma | ||
|
| Precocious puberty ”. | ||
8. Omit item 132, insert:— | ||||
“ 132 | Nalidixic Acid ........... | Urinary tract infections by organisms where sulphonamide treatment has proved ineffective and positive bacteriological evidence confirms that the organisms are sensitive to Nalidixic Acid or where the patient is sensitive to sulphonamides ”. | ||
9. Omit item 139, insert:— | ||||
“ 139 | (1) Nitrofurantoin Tablets, B.P. | Urinary tract infections by organisms where sulphonamide treatment has proved ineffective and positive bacteriological evidence confirms that the organisms are sensitive to Nitrofurantoin or where the patient is sensitive to sulphonamides ”. | ||
| (2) Nitrofurantoin Oral Suspension |
| ||
10. Omit item 173. | ||||
11. Omit item 180, insert:— | ||||
“ 180 | Pyridoxine Hydrochloride Tablets | Anaemia proved to be responsive to Pyridoxine | ||
|
| Convulsions responsive to Pyridoxine | ||
|
| Homocystinuria | ||
|
| Radiation sickness | ||
|
| Sideroblastic (refractory) anaemia | ||
|
| Treatment and prophylaxis of peripheral neuritis caused or likely to be caused by isoniazid therapy | ||
|
| With the written authority of the Director-General— Primary hyperoxaluria ”. | ||
12. Omit item 206, insert:— | ||||
“ 206 | Trimethoprim with Sulphamethoxazole | Infections by organisms sensitive to Trimethoprim with Sulphamethoxazole where the infection cannot be safely and effectively treated with other sulphonamides or with any of the following administered orally— | ||
|
| Benzylpenicillin | ||
|
| Phenoxymethylpenicillin | ||
|
| Phenethicillin | ||
|
| Urinary tract infections by organisms where other sulphonamide treatment has proved ineffective and positive bacteriological evidence confirms that the organisms are sensitive to Trimethoprim with Sulphamethoxazole | ||
|
| Ocular surgery ”. | ||
Printed by Authority by the Government Printer of the Commonwealth of Australia